Jazz Pharmaceuticals plc - FORM 8-K/A - EX-23.1 - CONSENT OF PRICEWATERHOUSECOOPERS LLP - August 10, 2012

Attached files

file filename
EX-99.3 - UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION - Jazz Pharmaceuticals plcd380594dex993.htm
EX-99.2 - UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS OF EUSA PHARMA INC - Jazz Pharmaceuticals plcd380594dex992.htm
EX-99.1 - AUDITED CONSOLIDATED FINANCIAL STATEMENTS OF EUSA PHARMA INC - Jazz Pharmaceuticals plcd380594dex991.htm
8-K/A - AMENDMENT NO. 1 TO FORM 8-K - Jazz Pharmaceuticals plcd380594d8ka.htm

Exhibit 23.1

Consent of Independent Auditors

We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (No. 133-179075) and on Form S-3 (No. 333-179080) of Jazz Pharmaceuticals Public Limited Company of our report dated April 2, 2012 relating to the consolidated financial statements of EUSA Pharma Inc. (now known as Jazz Pharmaceuticals (EUSA Pharma) Inc.), which appears in this Current Report on Form 8-K/A of Jazz Pharmaceuticals Public Limited Company.

/s/ PricewaterhouseCoopers LLP

Philadelphia, Pennsylvania

August 10, 2012

Stock widget

Investing forum

Jazz Pharmaceuticals plc Reports